GSE143782 calcitriol 6 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE143782_calcitriol_6_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE143782_calcitriol_6_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE143782_calcitriol_6_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE143782_calcitriol_6_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 3

Gene

multidrug resistance-related protein

Gene

small nucleolar RNA host gene 15

Gene

SLC16A1 antisense RNA 1

Gene

zinc finger domain-containing protein LOC728743

Gene

PRR34 antisense RNA 1

Gene

FMC1-LUC7L2 readthrough

Gene

ribonuclease P subunit p21

Gene

LHFPL3 antisense RNA 2

Gene

RNA component of 7SK nuclear ribonucleoprotein

  • Gene

    small nucleolar RNA host gene 3


  • Gene

    multidrug resistance-related protein


  • Gene

    small nucleolar RNA host gene 15


  • Gene

    SLC16A1 antisense RNA 1


  • Gene

    zinc finger domain-containing protein LOC728743


  • Gene

    PRR34 antisense RNA 1


  • Gene

    FMC1-LUC7L2 readthrough


  • Gene

    ribonuclease P subunit p21


  • Gene

    LHFPL3 antisense RNA 2


  • Gene

    RNA component of 7SK nuclear ribonucleoprotein

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.